Shares of this micro-cap stock, which offers a broad range of clinical and lifestyle solutions, gained after the inauguration of its advanced AI-powered ultrasound system at the Salt Lake clinic in Kolkata. The new system is anticipated to improve diagnostic accuracy and enhance procedure precision in multiple care areas.
Share Price Movement
During Thursday’s trading session, Nephro Care India Ltd’s share price reached an intra-day high of Rs.202.1 per share, hitting a 5 percent upper circuit from the previous close of Rs.192.50 apiece.
What is the news
Nephro Care India Limited (NCIL) unveiled a cutting-edge, voice-controlled, AI-powered ultrasound system at its flagship clinic in Salt Lake, Kolkata, on January 3, 2025.
The Logiq Totus, an advanced ultrasound machine, is designed to provide real-time scan guidance, improving operator efficiency, diagnostic precision, and the accuracy of procedures. This initiative aligns with NCIL’s commitment to making healthcare more accessible, affordable, and comprehensive.
Services Offered
Nephro Care India Ltd offers a comprehensive range of services focused on holistic kidney care. These include in-house and home dialysis options, specialized outpatient services in nephrology and diabetology, renal nutrition, and lifestyle modification programs.
The company also provides advanced diagnostic facilities for accurate kidney assessments, along with tailored home care services for patients who prefer treatment in the comfort of their homes.
Also read…..
Facility Developments
The main facility of Nephro Care India Ltd is situated in Salt Lake, Kolkata, spanning around 5,352 square feet, with additional satellite clinics in the area.
The center serves over 900 Chronic Kidney Disease (CKD) patients monthly, offering services including in-house dialysis, outpatient nephrology and diabetology care, advanced diagnostics, and home care options.
Financial Overview
In its latest financial update, the company reported net sales of Rs.271 crore for Q2 FY25, marking a 73 percent increase from Rs.157 crore in Q2 FY24. Additionally, net profits saw an exceptional rise of 1,250 percent, reaching Rs.27 crore, compared to Rs.2 crore during the same period last year. This impressive growth highlights the company’s strong financial performance.
About the Company
Nephro Care India Ltd, founded in 2014 and based in Kolkata, is a healthcare provider specializing in the treatment of kidney-related diseases. The company offers a holistic approach to kidney care, encompassing medication, lifestyle adjustments, and advanced medical treatments.
Written by – Siddesh S Raskar
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
Start Your Stock Market Journey Today!
Want to learn Stock Market trading and Investing? Make sure to check out exclusive Stock Market courses by FinGrad, the learning initiative by Trade Brains. You can enroll in FREE courses and webinars available on FinGrad today and get ahead in your trading career. Join now!!
